XTL Biopharmaceuticals Sponsored ADR (HHB0) Cash flow

0 Followers

XTL Biopharmaceuticals Sponsored ADR Cash Flow

DE:HHB0's free cash flow for Q4 2024 was $0.00. For the 2024 fiscal year, DE:HHB0's free cash flow was decreased by $647.00K and operating cash flow was $0.00. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -1.02M	$ -1.62M	$ -707.00K	$ -901.00K	$ -1.05M
Investing Cash Flow	$ 522.00K	$ -844.00K	$ 41.00K	$ 36.00K	$ 8.00K
Financing Cash Flow	$ 208.00K	$ 1.45M	$ 0.00	$ 0.00	$ 385.00K
End Cash Position	$ 76.00K	$ 371.00K	$ 1.40M	$ 2.09M	$ 2.97M
Free Cash Flow	$ -1.02M	$ -1.67M	$ -707.00K	$ -901.00K	$ -1.05M

Currency in USD